These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26085391)

  • 1. Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?
    Speicher PJ; Gu L; Wang X; Hartwig MG; D'Amico TA; Berry MF
    J Natl Compr Canc Netw; 2015 Jun; 13(6):755-61. PubMed ID: 26085391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Video-assisted thoracoscopic lobectomy mitigates adverse oncological effects of delayed adjuvant chemotherapy for nonsmall cell lung cancer patients.
    Jing X; Lin Y; Zhang B; Zhang G
    J BUON; 2016; 21(6):1524-1529. PubMed ID: 28039718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy Does Not Improve Survival for Lung Cancer With Chest Wall Invasion.
    Brown LM; Cooke DT; David EA
    Ann Thorac Surg; 2017 Dec; 104(6):1798-1804. PubMed ID: 29074150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall.
    Gao SJ; Corso CD; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
    Clin Lung Cancer; 2017 Mar; 18(2):169-177.e4. PubMed ID: 27890561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer.
    Ahmad U; Crabtree TD; Patel AP; Morgensztern D; Robinson CG; Krupnick AS; Kreisel D; Jones DR; Patterson GA; Meyers BF; Puri V
    Ann Thorac Surg; 2017 Jul; 104(1):303-307. PubMed ID: 28433225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
    Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
    Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
    Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
    Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
    Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection.
    Atay SM; Amini M; Ding L; David EA; Mcfadden PM; Wightman SC; Kim AW
    Ann Thorac Surg; 2021 Jul; 112(1):197-205. PubMed ID: 33121965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.
    Yang CF; Meyerhoff RR; Mayne NR; Singhapricha T; Toomey CB; Speicher PJ; Hartwig MG; Tong BC; Onaitis MW; Harpole DH; D'Amico TA; Berry MF
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1615-23. PubMed ID: 26719408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer.
    Williams CD; Gajra A; Ganti AK; Kelley MJ
    Cancer; 2014 Jul; 120(13):1939-47. PubMed ID: 24668613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer.
    Stokes SM; Massarweh NN; Stringham JR; Varghese TK
    Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
    Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
    Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
    Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
    Wakeam E; Adibfar A; Stokes S; Leighl NB; Giuliani ME; Varghese TK; Darling GE
    J Thorac Cardiovasc Surg; 2020 May; 159(5):2043-2054.e9. PubMed ID: 31759623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.